Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D in breast cancer
NCT00656019Phase 2Completed
- Sponsor
- Stanford University
- Start
- Apr 2008
- Primary completion
- Aug 2010
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, open-label trial of vitamin d in breast cancer, sponsored by Stanford University. Started Apr 2008; status: completed.
02
Drugs
vitamin d
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00656019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00656019.